Business and People Update September 2008

September 1, 2008
Applied Clinical Trials
Volume 0, Issue 0

Industry news focusing on the people and organizations who work in the clinical trials profession.

People

  • Alison Taber has joined Copernicus Group IRB (Research Triangle Park, NC) as the company's new chief operating officer.

Alison Taber

  • Kenneth G. Faulkner is the new vice president of Medical Imaging at Perceptive Informatics (Waltham, MA), the technology subsidiary of Parexel International Corporation (Boston, MA).

Kenneth G. Faulkner

  • Mark Reimer, PhD, will fill Pharsight Corporation's (Mountain View, CA) new position of senior director, operations and clinical development.

Mark Reimer

  • Sean Larkin, senior executive vice president of the Americas for late stage development at PharmaNet Development Group (Princeton, NJ), has also been appointed to the Metrics Champion Consortium (Carmel, IN) Board of Directors.

  • Pharsight Corporation's (Mountain View, CA) new position of senior associate, statistics and data management, will be filled by Jean-Sébastien Brunet.

  • The Drug Information Association (Horsham, PA) has announced six new members to its board: Jeffrey W. Sherman, as president-elect; Judith Glennie and Debbie J. Burns as directors; Sandra L. Kweder as the new special needs director; Jennifer L. Riggins as chair of the advisory council of North America; and Beat Widler as chair of the advisory council of Europe.

Paul Colvin

  • The Metrics Champion Consortium (Carmel, IN) has added Paul Colvin, RPh, the Association of Clinical Research Organization's (Washington, DC) senior vice president for clinical development, North America, to its Board of Directors.

  • Rib-X Pharmaceuticals, Inc. (New Haven, CT) has appointed George Milne, Jr., as the new executive chairman of its Board of Directors.

  • Carolyn Barley Britton, MD, an expert in Neurovirology and Infectious/Inflammatory Diseases of the nervous system, is now the 109th president of the National Medical Association (Washington, DC).

  • The Board of Active Biotech (Lund, Sweden) has appointed Tomas Leanderson as the company's new president and chief executive officer.

  • SAFE-BioPharma Association (Fort Lee, NJ) has named Tanya Newton as manager of regulatory affairs and compliance operations.

  • Penn Pharmaceutical Services (South Wales, UK) has brought on board two new personnel: Sue Price as head of clinical trial supplies and Pedro Pala as CTS project manager.

  • Aspire IRB (San Diego, CA) has appointed Currien MacDonald, MD, as its new medical director, and Robert Bourdon Daigneault, MD, has recently joined the Board.

  • Susan McNair-Maroney has recently been named the new account director for MedPoint Communications, Inc. (Evanston, IL).

  • INC Research (Raleigh, NC) has announced that Nick Kenny will serve as the company's new vice president of oncology.

  • Evelyn Graham will become the new chief executive officer of TorreyPines Therapeutics (La Jolla, CA) after serving as the company's chief operating officer since 2006.

  • Omnicare Clinical Research (King of Prussia, PA) has introduced Steven Pashko as the new senior vice president of global late phase, pharmacovigilance and safety.

  • With more than 25 years of experience in the industry, Ronald Kershner has been chosen to lead the North American Biostatistics and Data Management Services group for AAIPharma (Wilmington, NC).

Alliances

  • After repurchasing its assets from Radiant Research (Seattle, WA) in March 2007, Metroplex Clinical Research Center (Dallas, TX) has expanded into Phase I studies and experienced a 250% increase in business.

  • Pharmatech, Inc. (Denver, CO) has contracted with five pharmaceutical companies that will provide the research and site management services necessary for its new oncology clinical trials.

  • According to a recent agreement, Abingdon Life Sciences, Inc. (Carlsband, CA), is to provide Stason Pharmaceuticals (Irvine, CA) with clinical and regulatory services for its potential drug candidates and devices within the areas of cancer and inflammation.

  • Datatrak International (Mayfield Heights, OH) will utilize the services of Healthcare Growth Partners (Elmhurst, IL) as a strategic and financial advisor to its Board of Directors in order to provide assistance in the evaluation of potential opportunities to increase shareholder value.

  • Taiho Pharmaceutical (Tokyo, Japan), a specialty pharmaceutical company, will maintain its Phase III trial for cervical cancer with Medidata Solution's (New York, NY) Medidata Rave, an electronic data capture, management, and reporting system.

  • Pharsight Corporation (Mountain View, CA) and CRI Worldwide (Clementon, NJ) have combined their services in order to offer their customers broader solutions based on trial design, simulation, execution, analysis, and reporting.

  • In an effort to help increase the ability of pharmaceutical and life science companies conduct cognitive testing in clinical trials, United BioSource (Bethesda, MD) and CogState (New Haven, CT) have entered into a partnership in which customers will have use of both company's scientific resources, software capabilities, and global operations.

  • Eli Lilly (Indianapolis, IN) has agreed to a multiyear extension agreement with Phase Forward (Waltham, MA) in order to continue using its InForm product in future clinical trials.

  • Invacare (Elyria, OH) will utilize Sparta Systems' (Holmdel, NJ) TrackWise Quality Management Solution to electronically track and manage its product issues, complaints, adverse event assessments, and associated regulatory reporting processes.

  • The Academy of Pharmaceutical Physicians and Investigators (APPI; Washington DC) has taken part in the initiative to improve the quality and efficiency of clinical trials in the United States by joining the Clinical Trials Transformation Initiative (CTTI; Rockville, MD), which was recently established by the U.S. Food and Drug Administration and Duke University.

  • Pharsights' (Mountain View, CA) WinNonlin AutoPilot was purchased by a global biotechnology company, making it the seventh company to adopt the software.

  • Summit Drug and Development Services (Rockville, MD) has chosen to utilize Octagon Research Solutions' (Wayne, PA) ViewPoint and StartingPoint to aid in submission document authoring and integrated electronic regulatory submission management.

  • Huifeng Bio-Pharmaceutical Technology, Inc. (Xi'an, China) has entered into a supply agreement exceeding USD $1.1 million with DNP International (Santa Fe Springs, CA).

Awards

  • Workforce Alliance (West Palm Beach, FL) was awarded the U.S. Department of Labor's Recognition of Excellence Award in the category of "Educating America's Workforce to Serve Emerging Industries."

  • Covance (Princeton, NJ) was one of 12 suppliers awarded Merck's (Whitehouse Station, NJ) "Outstanding Strategic Collaboration Award" at its annual Supplier Recognition Forum.

  • Eli Lilly (Indianapolis, IN) has awarded Covance (Princeton, NJ) its 2008 Global Supplier Award based on its contributions in both innovation and technology.

Company News

  • The Octagon Research Solutions (Wayne, PA) Web site now contains a new Electronic Data Capture Blog entitled, "EDC Connections," which was developed to promote communication across the industry.

  • Velos (Fremont, CA) will implement Phase II of its strategic plan, which includes integrating with third-party systems as well as systems-based collaboration across research sites and sponsors.

  • Upon entering its fifth year in business, Aspire IRB (San Diego, CA) announces record growth for three consecutive years, including tripled sales and an annual gross of seven figures.

  • Clinilabs (New York, NY) has become a Mortara Certified Partner through Mortara Instrument (Milwaukee, WI), which according to the company allows it the capability of collecting, processing, and transmitting annotated ECG data compliant with ECG warehouse requirements.

  • QPS (Newark, DE) has added a new translational medicine department, which is a combination of the immunobiomarker and molecular biology groups, and it will be headed by LingSing K. Chen.

  • With the help of several years of preparation and dependable customer input, Velos (Fremont, CA) has announced that it will be crossing the 50% market penetration threshold by year-end, only five years after its product launch.

  • Xcelience (Tampa Bay, FL) has announced that it will use SCORR Marketing (Kearney, NE) as its agent to develop and implement marketing plans, brand development, public relations, media management, and tradeshow coordination.

  • Icon Medical Imaging (Warrington, PA) has announced that it is the first commercial imaging core laboratory to offer an integration of a Quantitative Coronary Angiographic (QCA) analysis with an electronic Case Report Form (eCRF).

Mergers/ Acquisitions

  • In order to create a new life science business unit, TÜV SÜD (Munich, Germany) has acquired all shares of MSOURCE, (Brussels, Belgium) which will serve as the CRO.

  • Parexel (Boston, MA) will acquire the entire share capital of ClinPhone (Nottingham, UK), a company traded on the London Stock Exchange, after its shareholders recently approved the acquisition.

  • In attempts to transform Eli Lilly's (Indianapolis, IN) R&D model, Covance (Princeton, NJ) will acquire Lilly's 450-acre early drug development campus in Greenfield, IN for $50 million.

New Facilities

  • Abingdon Life Sciences (Carlsbad, Ca) has formally opened offices in Carlsbad, CA.

  • To continue driving growth in the American, European, and Asian regions, Bilcare Global Clinical Supplies (San Francisco, CA) has opened a new global U.S. headquarters in San Francisco.

  • The U.S. Food and Drug Administration (Rockville, MD) plans to open two new offices in India next year, with intentions of enhancing how products being sent to America are monitored.
  • Omnicare Clinical Research (King of Prussia, PA) is going to be expanding its worldwide presence with the development of a new Swedish facility.